New approach to fighting obesity and diabetes
11 September, 2007
Scientists at the University of Queensland (UQ) are using specially designed equipment to determine how to produce food which is better for us, but still tastes good.
Genetic variant identification
10 September, 2007 | Supplied by: Applied Biosystems Pty Ltd
Variant Reporter software is designed to accelerate the analysis of genetic variation data. The Variant Reporter Software reduces manual review time of these data by automating the detection of genetic variants and streamlining the data analysis process. Applied Biosystems expects that the software can reduce by up to half the time currently required to evaluate genetic variation data generated during medical sequencing projects.
Blood banking test automation
10 September, 2007 | Supplied by: Australian Laboratory Services
BioTek Instruments has developed, in partnership with Immucor, an automated benchtop assay instrument for use in the blood transfusion industry. Manufactured by BioTek exclusively for Immucor, the Galileo Echo provides small to medium sized hospital blood bank laboratories with walk-away automation of tests such as ABO grouping and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping for significant increases in productivity and patient safety while taking less time than other methods.
Australian cancer drugs get a shot in the arm
05 September, 2007
Cancer Therapeutics (CTx) has commenced operations as one of the largest public/private partnerships of its type in the world.
Plant bank conserves its billionth species
31 August, 2007
The Millennium Seed Bank Project has collected its billionth variety from across the world for safekeeping and conservation. Simply gathered on the land, in woods and wetlands, the bank's deposits could hold the key to the globe's well-being and every creature that depends on it.
Rabbit milk drug to combat HAE
27 August, 2007
The clinical trial results of Rhucin, a drug for the treatment of Hereditary Angieoedema (HAE), will be presented at a press conference in London on 30 August.
What, oh, what are those actinides doing?
22 August, 2007
Researchers at Pacific Northwest National Laboratory are uniting theory, computation and experiment to discover exactly how heavy elements, such as uranium and technetium, interact in their environment.
Eureka for genetics and climate research
22 August, 2007
Two of Australia’s top researchers received awards last night at the Australian Museum Eureka Prizes Award Dinner at the Australian Technology Park, Sydney.
Alzheimer's researcher receives high honour
16 August, 2007
A neuroscientist was awarded the Victoria Prize, last night, for his groundbreaking research into Alzheimer's disease.
Scientists push for fusion energy in Australia
15 August, 2007
Australian scientists are today presenting at Parliament House a plan for the nation to develop fusion energy as a potentially safe and sustainable energy source.
A 'one-stop shop' for brain dysfunctions
10 August, 2007
A ‘one-stop shop’ for brain disorder information has been created, with the launch of the website www.florey.edu.au by the Howard Florey Institute, Australia’s leading brain research centre.
Scientists identify the oldest forms of life
08 August, 2007
Some of the oldest forms of life, confirmed to be 3.5 billion years-old, have been identified by a team of researchers at the University of Queensland.
237 reasons to have sex
06 August, 2007 by Janette Woodhouse, Editor
Many scientists assume people have sex for simple and straightforward reasons such as to experience sexual pleasure or to reproduce, but new research reveals hundreds of varied and complex motivations that range from the spiritual to the vengeful
NSW grants for life science research
01 August, 2007
The Iemma Government is offering grants of up to $100,000 to help life science companies commercialise their research, Minister for State Development Ian Macdonald announced today.
New research provides hope for childhood cancer sufferers
17 July, 2007
Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.
